Intuitive Surgical (NASDAQ:ISRG) will release its earnings data after the market closes on Monday, April 16th.
Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, January 25th. The medical equipment provider reported $2.54 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.27 by $0.27. The company had revenue of $892.40 million during the quarter, compared to analysts’ expectations of $866.54 million. Intuitive Surgical had a return on equity of 19.93% and a net margin of 21.09%. The business’s revenue for the quarter was up 17.9% on a year-over-year basis. During the same period last year, the firm earned $2.03 EPS. On average, analysts expect Intuitive Surgical to post $8 EPS for the current fiscal year and $9 EPS for the next fiscal year.
NASDAQ ISRG opened at $414.63 on Friday. The firm has a market capitalization of $46,926.42, a PE ratio of 57.67, a PEG ratio of 4.94 and a beta of 0.57. Intuitive Surgical has a 52 week low of $251.13 and a 52 week high of $452.00.
Several research firms have recently commented on ISRG. Vetr cut Intuitive Surgical from a “strong-buy” rating to a “buy” rating and set a $454.14 target price for the company. in a research note on Tuesday, April 10th. Zacks Investment Research cut Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Tuesday, March 27th. ValuEngine lowered Intuitive Surgical from a “hold” rating to a “sell” rating in a research report on Thursday, March 1st. BidaskClub upgraded Intuitive Surgical from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, February 21st. Finally, Citigroup reduced their price target on Intuitive Surgical to $507.00 and set a “buy” rating on the stock in a research report on Tuesday, February 6th. One analyst has rated the stock with a sell rating, six have issued a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company. The stock currently has a consensus rating of “Buy” and an average target price of $413.77.
In other Intuitive Surgical news, CEO Gary S. Guthart sold 28,525 shares of Intuitive Surgical stock in a transaction dated Monday, February 5th. The stock was sold at an average price of $414.50, for a total transaction of $11,823,612.50. Following the transaction, the chief executive officer now directly owns 311,469 shares in the company, valued at $129,103,900.50. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, SVP Mark J. Meltzer sold 24,000 shares of Intuitive Surgical stock in a transaction dated Tuesday, February 27th. The stock was sold at an average price of $433.00, for a total value of $10,392,000.00. Following the transaction, the senior vice president now owns 34,052 shares in the company, valued at $14,744,516. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 102,770 shares of company stock worth $43,410,836. Corporate insiders own 2.20% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This report was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this report on another website, it was illegally stolen and republished in violation of U.S. & international copyright law. The correct version of this report can be read at https://www.dispatchtribunal.com/2018/04/15/intuitive-surgical-isrg-scheduled-to-post-earnings-on-monday.html.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company's da Vinci surgical System translates a surgeon's natural hand movements, which are performed on instrument controls at a console into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.